chairS of thE conGrESS: dr mahmoud danaEi - Germanydr marc ESPiE - francedr didier vErhoEvEn - Belgiumdr adri vooGd - the netherlands

for any enqUiries pLease contact

cEntrE dE formation dES EditionS ESka (cfEE) - intErnational confErEncES

12, ruE du 4 SEPtEmBrE – 75002 PariS (francE) –tEl: +33 1 42 86 55 69 / 66 fax: +33 1 42 60 45 35

AACHEN GErmANy

13 -14 OCTOBEr 2017Venue: marienhospital, Zeise 4, 52060 Aachen-Germany

contact:SErGE kEBaBtchiEff (GEnEral dirEctor)adElinE marEchal (ProJEct manaGEr)WWW.congres.esKa.fr - congres@esKa.fr

ExEcutivE committEE

carol-ann Benn (South africa), mahmoud danaei (GErmany), marc espie (francE), carloS garcia-etienne (italy), hanS JUnKermann (GErmany), cary KaUfmann (uSa), SErGE KeBaBtchieff (francE),mauricio magaLhaes costa (Brazil), Shahla masood (uSa), luiS teiXeira (francE), didiEr

VerhoeVen (BElGium)

local orGanizinG committEE

rainald Bachmann (GErmany), mahmoud danaei (GErmany), StEfan handt (GErmany), hanS JUnKermann(GErmany), SErGE KeBaBtchieff (francE), SaBinE siesLing (nEthErlandS), luiS teiXeira (francE), didiEr VerhoeVen (BElGium), adri Voogd (nEthErlandS), SimonE WesseLmann (GErmany)

foundinG mEmBErS & PrEviouS committEES

StanlEy anyanWU (niGEria), WErnEr aUdretsch (GErmany), ahmad aWada (BElGium), carol-ann Benn(South africa), JacquES Bonneterre (francE), JoSEP Borras (SPain), EdWiGE BoUrstyn (francE), alBErto

costa (italy), mahmoud danaei (GErmany), marc espie (francE), carloS garBino (uruGuay) carloS

garcia-etienne (italy), markuS hahn (GErmany), hanS JUnKermann (GErmany), nikolay KateV(BulGaria), cary KaUfmann (uSa), SErGE KeBaBtchieff (francE), faBricE LecUrU (francE), mauricio

magaLhaes costa (Brazil), nikita manoKU (alBania), Shahla masood (uSa), Ezio noVais dias(Brazil), ruBEn orda (iSraEl), chriStof sohn (GErmany), corrado tinterri (italy), didiEr VerhoeVen(BElGium), diEthElm WaLLWiener (GErmany), tEPhanoS ZerVoUdis (GrEEcE)

Under the patronage of the mayor and the sUpport of stadt aachen

“Quality management, Innovation Promotion and Resource consideration”

June 30, 2017 After July, 1, 2017

Members of associated societies and centers 300 € □ 400 € □

Non-members associated societies and centers 450 € □ 550 € □

Corporate 500 € □ 600 € □

Nurses, midwifes, interns, students 125 € □ 125 € □

Lunches 80 € □ 90 € □

Congress dinner (October, 13, 2017) 100 € □ 100 € □

Friday, October 13

Saturday, October 14iBDC

International Breast Disense Centers

• THE REGiSTRATiON FEE covers the cost of the following items: • Scientific program • Coffee • Abstract volume • Delegates’congress bags and documentation • Subscription to the international Journal of Breast Disease Centers

• THE ACCOMPANYiNG PERSON FEE includes the welcoming party and free access to the social events organized by the sponsors.

DELEGATE REGiSTRATiON FORM

1 REGiSTRATiON FEES

3 REGiSTRATiON FORM

All registered participants are invited to submit an abstract for poster presentation. The best abstracts will be selected for oral pre-sentation. Abstracts should be sent to congres@eska.fr and didier.verhoeven@klina.be. Mandatory deadline for abstract reception:30/08/2017. The abstracts must comprise 1 to 3 pages in Word format and include a bibliography. Previous registration is neces-sary. Please follow the model available at: www.congres.eska.fr. For further information please contact us by e-mail. Only the abs-tracts received on time will be considered. Proposals for contributed papers are subject to approval by the Scientific Commitee.Abstracts of free papers will be published in the next issue of the International Journal of Breast Disease Centers.

CALL FOR POSTERS

TOTAL 1

Please return this form to: CFEE, Att: Mr. Serge KEBABTCHiEFF and Mrs. Adeline MARÉCHAL12, rue du Quatre-Septembre 75002 Paris (France) - Tel: +33 (1) 42 86 55 69/79 - Fax: +33 (1) 42 60 45 35 - email: congres@eska.fr

METHOD OF PAYMENTI am paying the following amount: _____________ □ CASH □ CHECK□ BANK TRANSFER: BNP Paribas - Paris Champs Elysées (00804), France

Account Holder: CFEE-ESKA - Compte N°: 30004 00804 00010139858 36 - IBAN Code FR76 3000 4008 0400 0101 3985 836

□ CREDIT CARD: □ Visa □ Mastercard Expiration date: I____I____I____I____I

Card holder________________________ Card No. I____I____I____I____I____I____I____I____I____I____I____I____I____I____I____I____I

DATE: SIGNATURE:

TOTALTO BE PAiD

2 TRANSPORTATiONAutomobiles: Parking for registered delegates (limited seating andpaying) Do you need a voucher for congress reduction in France:

Train (SNCF): yes □ no □Airplane (AiR-FRANCE): yes □ no □Registered delegates can benefit from preferential rates with Air Franceand KLM Global Meetings.

For more information go to:www.airfranceklm-globalmeetings.com

Name of the event: IBDC Aachen 2017 - Event Location: GermanyiD booking Code of the congress: TBAOverseas, contact the Air France reservation center in your countrywith the ID code of the congress.

Please write the MAXIMUM information in CAPITAL LETTERS

Last Name: Firt Name: Title:

Hospital/University/Private Practice

Addresse:

Postal Code: City: Country:

Téléphone: Fax: Mobile:

E-mail: (imperative)

2017international Congress7thof Breast Disease Centers

TOTAL 2

EXPECTED SESSiONS (iN PROGRESS)

SESSiON 1: EARLY DiAGNOSiS AND SCREENiNG

SESSiON 2: DEBATE: QUALiTY MANAGEMENT AND ONCOPOLiCY : STAKEHOLDERS ViEWPOiNT

SESSiON 3: iNTRODUCiNG NEW TECHNOLOGiES

SESSiON 4: LOCO-REGiONAL TREATMENT

SESSiON 5: SYSTEMiC TREATMENT

SESSiON 6: MULTiDiSCiPLiNARY MEETiNG AND BENCHMARKiNG

FRiDAY 13 OCTOBER 2017 SATURDAY 14 OCTOBER 2017

32249AF

7th IBDC 2017 1ST PROG 6P_Mise en page 1 06/09/17 17:43 Page1

LETTER OF WELCOMEDear colleagues,

We are pleased to announce the seventh International congress of Breast Disease centers.

This event will take place in Aachen, Germany on 13-14 October 2017. It will gather a great set clinicianscoming from the major centers involved in the detection, prevention and treatment of breast diseases and will besupported by national and international societies or centers of oncology, gynecology, mastology, and radiology.

We have enlarged the Board of the Directors of Breast Disease centers associated with this seventh inter-national congress, and to prepare the 2017 congress and it was decided to structure the congress around four the-matic chapters:

o Managment of Breast centerso Diagnosiso Treatmentso Training, teaching and support

The key medical specialists of these disciplines have been invited and they warmly support this project.

The response from national delegations has already been extremely positive throughout europe and othercontinents and we are expecting a strong level of participation internationally.

We look forward to your active participation in this innovative event and to welcoming you in Aachennext, October.

yours sincerelyDr Mahmoud DANAEIMarienhospital, Zeise 4, 52060 Aachen-Germany

Organizing Committee: Adeline MARECHAL congres@eska.fr - Serge KEBABTCHIEFF serge.kebabtchieff@eska.frCFEE, 12 rue du Quatre Septembre, 75002 Paris FRANCE - Tel. : +33 1 42 86 55 69 - Fax. : +33 1 42 60 45 35

iBDCInternational Breast Disense Centers

FRIDAy, OCTOBER 13QUALITy MANAGEMENT, INNOVATION PROMOTION AND RESOURCE CONSIDERATION

10.30-11.00 iNTRODUCTiON Mahmoud DANAEi (Germany)

Guatami TADiMALLA (Life again Foundation, India)

11.00-11.30 KEYNOTE • Breast cancer 2020: A global and personalised vision

Sabine VERHEYEN (Member of the European Parliament)

11.30-13.00 SESSiON 1: EARLY DiAGNOSiS AND SCREENiNGChairs: Hans JUNKERMANN, Berthold WEiN, Adri VOOGD• A global perspective to control breast cancer Claudia ALLEMANi (UK)

• Newest development in mammography screening, ready for clinical use?Hans JUNKERMANN (Germany)

• Personalized risk based follow-up in breast cancer: reallocation of care?Sabine SiESLiNG (The Netherlands)

• Risk adopted screening, what can be gained Alexander KATALiNiC* (Germany)

• Effects on mammographic programs on breast cancer treatmentin the Aachen region Angela SPELSBERG (Germany)

• Tomosynthesis – What we know and what we should know Kathrin ENTz* (Germany)

• Minimal invasive Mammaintervention – State of the art Uwe PEiSKER (Germany)

13.00-14.00 LUNCH

14.00-15.30 SESSiON 2: DEBATE: QUALiTY MANAGEMENT AND ONCOPOLiCY: STAKEHOLDERS ViEWPOiNT

14.00-14.15 Chairs: Luis TEiXEiRA, Sabine SiESLiNG, Didier VERHOEVENSetting the scene: What means quality management in breast disease centres? Jumana MENSAH (Germany)From evidence to quality improvement Simone WESSELMANN (Germany)

DEBATE• Authorities/University Adri VOOGD (Netherland) 10’

• Assurance/Social security Matthias MOHRMANN* (Germany) 10’Frank BERGMANN* (Germany)

• Medical Profession/Media Jane KAKKiS (US) 10’

• Patients advocacy/Nursing Gerda GORRiSSEN (Germany) 10’

• Developing countries Carol BENN (South-Africa) 10’

• Tumor center Angela SPELSBERG (Germany) 10’

• Debate and discussion 15’

15.30-16.00 COFFEE BREAK

16.00-17.30 SESSiON 3: iNTRODUCiNG NEW TECHNOLOGiESChairs: Shahla MASOOD, Stefan HANDT• New molecular diagnostics (NGS, liquid biopsy): Doing more, with less ! Shahla MASOOD (US)

• Determination genetic risk K. RHiEM (Germany)

• Bridging the gap between Breast cancer research and real practice Sabine SiESLiNG (The Netherlands)

• Affordability and cost-effectiviness of new technology Luis TEiXEiRA, Marc ESPiÉ (France)

• A new point of treatment approach: Epigenetics

18.30-19.30 CULTURAL EVENT

20.00 CONGRESS DiNNER * TBC = to be confirmed

iBDCInternational Breast Disense Centers

SATURDAy, OCTOBER 14QUALITy MANAGEMENT, INNOVATION PROMOTION AND RESOURCE CONSIDERATION

09.00-9.30 KEYNOTE

• The best surgical quality for each patient Mahmoud DANAEi (Germany)

09.30-11.00 SESSiON 4: LOCO-REGiONAL TREATMENT

Chairs: Mahmoud DANAEi, Shahla MASOOD, Stefan HANDT

• Assessment of Neo-adjuvant chemotherapy: Radiology-Pathology Rainald BACHMANN (Germany), Shahla MASOOD (USA)

• State of the art and perspectives of neo/adjuvant treatment of breast cancer Elmar STiCKELER (Germany)

• Accuracy, outcome and cost in innovative radiotherapy Dirk de RUYSSCHER* (The Netherlands)

• Type and timing of reconstruction and preventive surgery Mauricio MAGALHAES COSTA (Brazil)

• Avoiding ALND after a positive SNLB: practice patterns in US and Europe Carlos GARCiA-ETiENNE (Italy)

• Topical cutaneous and mucosal use of alpha-tocopheryl acetate: from biochemistry to clinical evidence Giorgio PANiN (Italy)

• Silicon in the breast and axilla US-Diagnostic and Therapy Uwe PEiSKER (Germany)

11.00-11.30 COFFEE BREAK

11.30-12.00 KEYNOTE

• Awareness Carol-Ann BENN (South-Africa)

12.00-13.00 SESSiON 5: SYSTEMiC TREATMENT

Chairs: Barmak ADHAMi, Dagmar SWORDS, Dirk TUMMES

• Is Age a important factor in decision of systemic treatment? Marc ESPiÉ, Luis TEiXEiRA (France)

• The upcoming role of liquid biopsy in systemic breast cancer treatment Leonhard HABETS (Germany)

• Quality indicators in systemic treatment Didier VERHOEVEN (Belgium)

13.00-14.00 LUNCH

14.00-16.00 SESSiON 6: MULTiDiSCiPLiNARY MEETiNG AND BENCHMARKiNG

Chairs: Mahmoud DANAEi, Didier VERHOEVEN, Marc ESPiÉ

14.00-14.15 • Minimal requirements of Tumor Board and MDM Adri VOOGD (The Netherlands)

14.15-14.30 • Quality indicators for Breast Cancer Centers: Simone WESSELMANN (Germany)How can we use the results?

14.30-16.00 • Clinico-pathologic conference by International experts Shahla MASSOOD,Mauricio MAGALHAES COSTA, Ezio NOVAiS

Jane KAKKiS, Luis TEiXEiRA, Carol-Ann BENN,Dirk DE RUYSSCHER*, Hans JUNKERMANN

5 cases presented by the Aachener team

Mared ATTASSi, Rainald BACHMANN, Leonhard HABETS, Stefan HANDT, Esther GELLER, Dagmar SWORDS

RECEPTiON* TBC = to be confirmed

iBDCInternational Breast Disense Centers

FRIDAy, SATURDAy, OCTOBER 13-14QUALITy MANAGEMENT, INNOVATION PROMOTION AND RESOURCE CONSIDERATION

WITH THE SUPPORT OF

7th IBDC 2017 1ST PROG 6P_Mise en page 1 06/09/17 17:43 Page4